Prevalence of tumor necrosis factor-α and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 1, 1999, Pages 278-282

  Chagani, Tabassum ^b   Paré, Peter D ^b   Zhu, Shoukang ^b   Weir, Tracey D ^b   Bai, Tony R ^b   Behbehani, Nasser A ^b   Fitzgerald, J Mark ^b   Sandford, Andrew J ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; ASTHMA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME POLYMORPHISM; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032802115     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.1.9808032     Document Type: Article

References (29)

1. Sandford, A., T. Weir, and P. Paré, 1996. The genetics of asthma. Am. J. Respir. Crit. Care Med. 153:1749-1765.
2. Carrol, M. C., P. Katman, E. M. Alicot, B. H. Koller, D. E. Geraghty, H. T. Orr, J. L. Strominger, and T. Spies. 1987. Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc. Natl. Acad. Sci. U.S.A. 84:8535-8539.
3. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Huesser, P. H. Howarth, and S. T. Holgate. 1994. Interleukin-4, -5, and -6 and Tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cells as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:471-480.
4. Virchow, J. C., C. Walker, D. Hafner, C. Kortsik, P. Werner, H. Matthys, and C. Kroegel. 1995. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am. J. Respir. Crit. Care Med. 151:960-968.
5. Broide, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J, Allergy Clin. Immunol. 89:958-967.
6. Gusset, P., A. Tsicopoulas, and B. Wallaert. 1992. Tumor necrosis factor and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. Am. Rev. Respir. Dis. 146:768-774.
7. Nadospasov, S. A., A. N. Shakov, R. L. Turetskaya, V. A. Mett, M. M. Azizov, G. P. Georgiev, V. G. Korobko, V. N. Dobrynin, S. A. Fillipov, N. S. Bystrov, E. F. Boldyreva, S. A. Chuvpilo, A. M. Chumakov, L. N. Shingarova, and Y. A. Ovchinnikov. 1986. Tandem arrangement of genes coding for tumor necrosis factor (TNF-α) in the human genome. Cold Spring Harbor Symp. Quant. Biol. 511:611-624.
8. Wilson, A. G., J. A. Symons, T. L. McDowell, H. O., McDevitt, and G. W. Duff. 1997. Effects of a tumor necrosis factor (TNT-α) 0romoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 94:3195-3199.
9. Moffatt, M. F., and W. O. C. M. Cookson. 1997. Tumor necrosis factor haplotypes and asthma. Immunol. Genet. 6:551-554.
10. Erdos, E. G., and H. Y. T. Yang. 1967. An enzyme in microsomal fraction of the kidney that inactivates bradykinin. Life Sci. 6:569-574.
11. Erdos, E. G. 1990. Angiotensin 1 converting enzyme and the changes in our concept through the years. Hypertension 16:363-370.
12. Johnson, A. R., J. Ashton, W. W. Shulz, and E. G. Erdos. 1985. Neutral metalloperoxidase in human lung tissue and cultured cells. Am. Rev. Respir. Dis. 132:564-568.
13. Hubert, C., A. M. Houot, P. Corvol, and F. Soubrier. 1991. Structure of the angiotensin-1 converting enzyme gene. J. Biol. Chem. 266:15377-15383.
14. Rigat, B., C, Hubert, F. Ahlenc-Gelas, F. Cambien, P. Corvol, and F. Soubrier. 1990. An insertion-deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1343-1346.
15. Costerousse, O., J. Allegrini, M. Lopez, and F. Ahlene-Gelas. 1993. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T lymphocytes. J. Biochem. 290:33-40.
16. Benessiano, J. B. Crestani, F. Mestari, W. Klouche, F. Neukrich, S. Hacein-Bey, G. Durand, and M. Aubrier. 1997. High frequency of a deletion polymorphism of the angiotensin converting enzyme gene in asthma. J. Allergy Clin. Immunol. 99:52-57.
17. Sambrook, J., F. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, NY, 16-18.
18. Cooper, C. S., and M. R. Stratton. 1991. Extraction and enzymatic amplification of DNA from paraffin-embedded specimens. In C. Mathews, editor. Methods in Molecular Biology, Vol. 9: Protocols in Human Molecular Genetics. Humana Press, Totowa, NJ. 133-40.
19. Rigat, B., C. Hubert, P. Corvol, and F. Soubrier. 1992. PCR detection of the insertion/deletion polymorphism of the human angiotensin 1 converting enzyme gene (DCP1). Nucleic Acids Res. 20:1433.
20. Wilson, A. G., F. S. di Giovine, and G. W. Duff. 1995. Genetics of tumor necrosis factor-α in autoimmune, infectious, and neoplastic disease. J. Inflamm. 45:1-12.
21. McManus, R., A. G. Wilson, J. Mansfield, D. G. Weir, G. W. Duff, and D. Kelleher. 1996. TNF2, a polymorphism of the tumor necrosis-α gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur. J. Immunol. 26:2113-2118.
22. McGuire, W., A. V. S. Hill, C. E. M. Allsop, B. M. Greenwood, and D. Kwlatkowski. 1994. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371:508-511.
23. Stuber, F., I. A. Udalova, M. Book, L. N. Drutskaya, D. V. Kuprash, R. L. Turetskaya, F. U. Schade, and S. A. Nedospasov. 1996. 308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysacharide inducibility of the human TNF promoter. J. Inflamm. 46:42-50.
24. Brinkman, B. M. N., D. Zuijdgeest, E. L. Kaijzel, F. C. Breedveld, and C. L. Verweij. 1996. Relevance of the tumor necrosis factor-alpha (TNF-α) -308 promoter polymorphism in TNF-α gene regulation J. Inflamm. 46:32-41.
25. Wilson, A. G., N. deVaries, F. Pociot, F. S. di Giovine, L. B. A. van der Putte, and G. W. Duff. 1993. An allelic polymorphism within the tumor necrosis factor-α promoter region is strongly associated with HLA A1, D8, and DR3 alleles. J. Exp. Med. 177:557-560.
26. LeSon, S., and M. E. Gershwin. 1996. Risk factors for asthmatic patients requiring intubation: III. Observation in young adults. J. Asthma 33: 27-35.
27. Christensen, S. C., D. Proud, and C. G. Cochrane. 1987. Detection of kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J. Clin. Invest. 79:188-197.
28. Abe, K., N. Watanabe, N. Kumagai, T. Mouri, T. Seki, and K. Yoshinaga. 1967. Circulating plasma kinin in patients with bronchial asthma. Experientia 23:626-627.
29. Kohno, M., T. Hario, K. Yokokawa, N. Kurihara, and T. Taheda. 1992. C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3′, 5′-monophosphate. Hypertension 19:320-325.